Jianqin Lu

Research Interests

Jianqin Lu, B.Pharm., PhD, Assistant Professor of Pharmaceutical Sciences in Pharmaceutics and Pharmacokinetics, College of Pharmacy. The overarching goal of the Lu lab is to apply synthetic chemistry, nanoparticle engineering, and tumor immunology to develop efficacious nanotherapeutics to address the pressing unmet needs in current cancer therapy. Dr. Lu’s graduate research focused on developing functional nanocarriers for synergistic tumor targeted delivery of chemotherapeutics for improved anticancer efficacy and reduced side effects for treating breast, prostate, and cervical tumors. During his postdoctoral training, Dr. Lu developed a nano-enabled cancer immuno-therapeutics platform via instigating the immunogenic cell death (ICD) and inhibiting the immunosuppressive IDO metabolic immune checkpoint. Dr. Lu was the recipient of the Norman R. and Priscilla A. Farnsworth Award at University of Pittsburgh, and USHHS Ruth L. Kirschstein Institutional National Research Service Award in Tumor Immunology among others. Dr. Lu has published 25 research articles, 1 book chapter, and 2 patent applications (One has been licensed) as well as been the invited speaker in the prestigious 41st Controlled Released Society Annual Meeting & Exposition. Dr. Lu received a PhD degree in Pharmaceutics from University of Pittsburgh (2014), and completed a NIH Postdoctoral Fellowship at Department of Chemistry, The University of Chicago (2015), and a NIH Postdoctoral Fellowship in Nanomedicine/Tumor Immunology at California NanoSystems Institute at UCLA (2019), respectively.